Decarboxylases involved in polyamine biosynthesis and their inactivation by nitric oxide.
暂无分享,去创建一个
[1] F. Murad,et al. Novel effects of nitric oxide. , 2003, Annual review of pharmacology and toxicology.
[2] Robert H. White,et al. Methanococcus jannaschii Uses a Pyruvoyl-dependent Arginine Decarboxylase in Polyamine Biosynthesis* , 2002, The Journal of Biological Chemistry.
[3] C. Klein. Nitric oxide and the other cyclic nucleotide. , 2002, Cellular signalling.
[4] Per-Ola Norrby,et al. S-adenosylmethionine conformations in solution and in protein complexes: conformational influences of the sulfonium group. , 2002, Biochemistry.
[5] L. Rudolph-Owen,et al. Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[6] G. Murphy,et al. Long-range interactions in the dimer interface of ornithine decarboxylase are important for enzyme function. , 2001, Biochemistry.
[7] L. Ignarro,et al. Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] W. Tolbert,et al. Structure of a human S-adenosylmethionine decarboxylase self-processing ester intermediate and mechanism of putrescine stimulation of processing as revealed by the H243A mutant. , 2001, Biochemistry.
[9] S E Ealick,et al. The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase. , 2001, Biochemistry.
[10] P. Coffino,et al. Antizyme, a mediator of ubiquitin-independent proteasomal degradation. , 2001, Biochimie.
[11] P. Woster,et al. Terminally alkylated polyamine analogues as chemotherapeutic agents. , 2001, Journal of medicinal chemistry.
[12] E. Goldsmith,et al. Altering the reaction specificity of eukaryotic ornithine decarboxylase. , 2000, Biochemistry.
[13] S. Cederbaum,et al. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. , 2000, Cancer research.
[14] D. Reis,et al. Characterization of Arginine Decarboxylase in Rat Brain and Liver , 2000, Journal of neurochemistry.
[15] N. Grishin,et al. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding. , 2000, Journal of molecular biology.
[16] A. Pegg,et al. Mechanistic Studies of the Processing of Human S-Adenosylmethionine Decarboxylase Proenzyme , 1999, The Journal of Biological Chemistry.
[17] N. Grishin,et al. X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine. , 1999, Biochemistry.
[18] L. Ignarro,et al. Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. , 1999, Biochemical and biophysical research communications.
[19] A. Kern,et al. Structure of mammalian ornithine decarboxylase at 1.6 A resolution: stereochemical implications of PLP-dependent amino acid decarboxylases. , 1999, Structure.
[20] I. Mathews,et al. The crystal structure of human S-adenosylmethionine decarboxylase at 2.25 A resolution reveals a novel fold. , 1999, Structure.
[21] A. Pegg,et al. Role of cysteine-82 in the catalytic mechanism of human S-adenosylmethionine decarboxylase. , 1999, Biochemistry.
[22] L. Shantz,et al. Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation. , 1996, Cancer research.
[23] A. Pegg,et al. Rapid exchange of subunits of mammalian ornithine decarboxylase. , 1994, The Journal of biological chemistry.
[24] A. Pegg,et al. Spermidine/spermine N1‐acetyltransferase — the turning point in polyamine metabolism , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] L. Shantz,et al. Purification of human S-adenosylmethionine decarboxylase expressed in Escherichia coli and use of this protein to investigate the mechanism of inhibition by the irreversible inhibitors, 5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine and 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosin , 1992, Biochemistry.
[26] A. Pegg,et al. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites. , 1992, The Journal of biological chemistry.
[27] A. Pegg,et al. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. , 1988, Cancer research.
[28] A. Pegg,et al. Acetylation of decarboxylated S-adenosylmethionine by mammalian cells. , 1986, Biochemistry.
[29] A. Pegg. The role of polyamine depletion and accumulation of decarboxylated S-adenosylmethionine in the inhibition of growth of SV-3T3 cells treated with alpha-difluoromethylornithine. , 1984, The Biochemical journal.
[30] Aled Edwards,et al. The crystal structure of spermidine synthase with a multisubstrate adduct inhibitor , 2002, Nature Structural Biology.
[31] Seymour S. Cohen. A Guide to the Polyamines , 1998 .
[32] L. Marton,et al. Polyamines as targets for therapeutic intervention. , 1995, Annual review of pharmacology and toxicology.
[33] P. McCann,et al. S-adenosylmethionine decarboxylase as an enzyme target for therapy. , 1992, Pharmacology & therapeutics.